2 research outputs found
Differential efficacy of bortezomib in subtypes of diffuse large Bâcell lymphoma (dlbl): a prospective randomised study stratified by transcriptome profiling: remodlâB
DLBL subtypes identified by patterns of gene expression correspond to germinal center (GCB) or activated (ABC) Bâcells like. The latter demonstrate dysregulation of the NFâKB pathway. Outcomes of treatment with RâCHOP are inferior for ABC DLBL in retrospective series. This study investigated whether adding bortezomib (B),a putative NFâKB inhibitor, can reverse this phenotype
DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B-CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL-B
Effect of esculetin on HEK293 cancer cells: Effect of different concentrations of esculetin on cell viability using MTT assay in HEK 293 cell line. Data represents the meanâ±âSD of three independent experiments. (TIF 23 kb